NeoGenomics, Inc. (ADR)
General ticker "NEO" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $260.4M (TTM average)
NeoGenomics, Inc. (ADR) follows the US Stock Market performance with the rate: 8.7%.
Estimated limits based on current volatility of 1.8%: low 11.98$, high 12.41$
Factors to consider:
- Total employees count: 2200 as of 2024
- Top business risk factors: Labor/talent shortage/retention, Cybersecurity threats, Manufacturing capacity constraints, Technological obsolescence, Acquisition/divestiture risks
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.86$, 19.59$]
- 2025-12-31 to 2026-12-31 estimated range: [8.58$, 17.50$]
Financial Metrics affecting the NEO estimates:
- Positive: with PPE of 167.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.25 <= 0.84
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 55.09 <= 63.39
- Positive: Investing cash flow per share per price, % of 3.03 > -0.66
- Negative: 0.79 < Interest expense per share per price, % of 1.56
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Negative: Operating cash flow per share per price, % of 1.66 <= 6.82
Short-term NEO quotes
Long-term NEO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $509.73MM | $591.64MM | $660.57MM |
| Operating Expenses | $667.35MM | $699.38MM | $752.67MM |
| Operating Income | $-157.62MM | $-107.74MM | $-92.11MM |
| Non-Operating Income | $-1.72MM | $10.64MM | $11.43MM |
| Interest Expense | $7.58MM | $6.91MM | $6.62MM |
| R&D Expense | $30.33MM | $27.31MM | $31.16MM |
| Income(Loss) | $-159.34MM | $-97.10MM | $-80.67MM |
| Taxes | $-15.09MM | $-9.13MM | $-1.95MM |
| Profit(Loss)* | $-144.25MM | $-87.97MM | $-78.73MM |
| Stockholders Equity | $998.02MM | $941.54MM | $902.34MM |
| Inventory | $24.28MM | $24.16MM | $26.75MM |
| Assets | $1,740.03MM | $1,681.23MM | $1,638.04MM |
| Operating Cash Flow | $-65.99MM | $-1.95MM | $7.02MM |
| Capital expenditure | $30.89MM | $28.75MM | $41.06MM |
| Investing Cash Flow | $0.52MM | $76.71MM | $12.86MM |
| Financing Cash Flow | $11.83MM | $4.55MM | $4.65MM |
| Earnings Per Share** | $-5.81 | $-3.50 | $-3.11 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.